American International Group, Inc. Graybug Vision, Inc. Transaction History

American International Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.53 - $6.1 $393,845 - $680,583	-111,571 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.55 - $35.0 $598,151 - $3.77 Million	107,775 Added 2839.17%	111,571 $619,000
Q4 2020 Feb 12, 2021	BUY	$13.05 - $33.93 $49,537 - $128,798	3,796 New	3,796 $110,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.